{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:24:50Z","timestamp":1740176690125,"version":"3.37.3"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-04139-x","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T12:02:11Z","timestamp":1713873731000},"page":"1677-1698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-8823","authenticated-orcid":false,"given":"Priya","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laith","family":"Abandeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Aboughalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefe","family":"Pooyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Mansoori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"issue":"5","key":"4139_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1067\/j.cpradiol.2013.02.001","volume":"42","author":"S Osman","year":"2013","unstructured":"Osman, S., et al., A comprehensive review of the retroperitoneal anatomy, neoplasms, and pattern of disease spread. Curr Probl Diagn Radiol, 2013. 42(5): p. 191-208.","journal-title":"Curr Probl Diagn Radiol"},{"key":"4139_CR2","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1016\/B978-0-323-08299-0.05001-X","volume-title":"Nuclear Medicine","author":"HA Ziessman","year":"2014","unstructured":"Ziessman, H.A., et al., Preface, in Nuclear Medicine (Fourth Edition), H.A. Ziessman, J.P. O\u2019Malley, and J.H. Thrall, Editors. 2014, W.B. Saunders: Philadelphia. p. ix.","edition":"4"},{"key":"4139_CR3","unstructured":"ACR\u2013ACNM\u2013SNMMI\u2013SPR practice parameter for performing FDG-PET\/CT in oncology 2021; Available from: https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Practice-Parameters\/fdg-pet-ct.pdf."},{"issue":"2","key":"4139_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1148\/rg.322115032","volume":"32","author":"T Tirkes","year":"2012","unstructured":"Tirkes, T., et al., Peritoneal and retroperitoneal anatomy and its relevance for cross-sectional imaging. Radiographics, 2012. 32(2): p. 437-51.","journal-title":"Radiographics"},{"issue":"2","key":"4139_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard, R., et al., FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging, 2015. 42(2): p. 328-54.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"4139_CR6","first-page":"885","volume":"47","author":"D Delbeke","year":"2006","unstructured":"Delbeke, D., et al., Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0. J Nucl Med, 2006. 47(5): p. 885-95.","journal-title":"J Nucl Med"},{"issue":"4","key":"4139_CR7","first-page":"368","volume":"12","author":"H FahimUl","year":"2012","unstructured":"Fahim Ul, H. and G.J. Cook, PET\/CT in oncology. Clin Med (Lond), 2012. 12(4): p. 368-72.","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"4139_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1148\/radiographics.18.4.9672967","volume":"18","author":"HJ Vesselle","year":"1998","unstructured":"Vesselle, H.J. and F.D. Miraldi, FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics, 1998. 18(4): p. 805-23; discussion 823-4.","journal-title":"Radiographics"},{"issue":"2","key":"4139_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1148\/rg.2017160059","volume":"37","author":"A Lakhani","year":"2017","unstructured":"Lakhani, A., et al., FDG PET\/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging. Radiographics, 2017. 37(2): p. 577-594.","journal-title":"Radiographics"},{"issue":"1","key":"4139_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1148\/rg.271065080","volume":"27","author":"HB Prabhakar","year":"2007","unstructured":"Prabhakar, H.B., et al., Bowel hot spots at PET-CT. Radiographics, 2007. 27(1): p. 145-59.","journal-title":"Radiographics"},{"issue":"11","key":"4139_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12149-020-01509-z","volume":"34","author":"N Schreuder","year":"2020","unstructured":"Schreuder, N., et al., Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48\u00a0h sufficient? Ann Nucl Med, 2020. 34(11): p. 833-839.","journal-title":"Ann Nucl Med"},{"issue":"2","key":"4139_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1148\/rg.332125085","volume":"33","author":"RO Caiafa","year":"2013","unstructured":"Caiafa, R.O., et al., Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics, 2013. 33(2): p. 535-52.","journal-title":"Radiographics"},{"issue":"2","key":"4139_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","volume":"39","author":"PJ Scheel","year":"2013","unstructured":"Scheel, P.J., Jr. and N. Feeley, Retroperitoneal fibrosis. Rheum Dis Clin North Am, 2013. 39(2): p. 365-81.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"4139_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.juro.2010.09.105","volume":"185","author":"AS Brandt","year":"2011","unstructured":"Brandt, A.S., et al., Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol, 2011. 185(2): p. 526-31.","journal-title":"J Urol"},{"issue":"2","key":"4139_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2214\/AJR.07.3629","volume":"191","author":"CG Cronin","year":"2008","unstructured":"Cronin, C.G., et al., Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol, 2008. 191(2): p. 423-31.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"4139_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","volume":"21","author":"I Jansen","year":"2010","unstructured":"Jansen, I., et al., (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med, 2010. 21(3): p. 216-21.","journal-title":"Eur J Intern Med"},{"issue":"supplement 1","key":"4139_CR17","first-page":"2145","volume":"53","author":"C Angelina","year":"2012","unstructured":"Angelina, C., et al., 18F-FDG PET\/CT in management of retroperitoneal fibrosis: A promising tool. Journal of Nuclear Medicine, 2012. 53(supplement 1): p. 2145.","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"4139_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","volume":"39","author":"G Moroni","year":"2012","unstructured":"Moroni, G., et al., The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging, 2012. 39(10): p. 1635-42.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"4139_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1148\/radiol.2021210646","volume":"301","author":"J Polo-Sabau","year":"2021","unstructured":"Polo-Sabau, J. and B. L\u00f3pez-Botet-Zulueta, Massive Perirenal Involvement in Erdheim-Chester Disease. Radiology, 2021. 301(2): p. 278-278.","journal-title":"Radiology"},{"key":"4139_CR20","unstructured":"Nikpanah, M., et al., (2019) Pictorial Review of the 18F-FDG PET\/CT Manifestations of Erdheim-Chester Disease. Vol. 60: 1141\u20131141."},{"issue":"5","key":"4139_CR21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2967\/jnumed.117.200741","volume":"59","author":"JR Young","year":"2018","unstructured":"Young, J.R., et al., (18)F-FDG PET\/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker. J Nucl Med, 2018. 59(5): p. 774-779.","journal-title":"J Nucl Med"},{"issue":"4","key":"4139_CR22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00259-020-05047-8","volume":"48","author":"J Kirchner","year":"2021","unstructured":"Kirchner, J., et al., (18)F-FDG PET\/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study. Eur J Nucl Med Mol Imaging, 2021. 48(4): p. 1154-1165.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"4139_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4103\/0973-1482.150359","volume":"11","author":"D Qiu","year":"2015","unstructured":"Qiu, D., et al., Extramedullary hematopoiesis on 18F-FDG PET\/CT in a patient with thalassemia and nasopharyngeal carcinoma: A case report and literature review. J Cancer Res Ther, 2015. 11(4): p. 1034.","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"4139_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s13139-022-00773-3","volume":"56","author":"SE Dahlsgaard-Wallenius","year":"2022","unstructured":"Dahlsgaard-Wallenius, S.E., et al., Extramedullary Hematopoiesis Visualized on FDG-PET\/CT in a Patient with Beta-Thalassemia. Nuclear Medicine and Molecular Imaging, 2022. 56(6): p. 328-330.","journal-title":"Nuclear Medicine and Molecular Imaging"},{"issue":"7","key":"4139_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/MNM.0000000000001404","volume":"42","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., et al., 18F-FDG PET\/CT imaging features of patients with multicentric Castleman disease. Nucl Med Commun, 2021. 42(7): p. 833-838.","journal-title":"Nucl Med Commun"},{"key":"4139_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10120998","author":"EJ Han","year":"2020","unstructured":"Han, E.J., et al., FDG PET\/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings. Diagnostics (Basel), 2020. 10(12).","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"4139_CR27","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1038\/s41598-020-69854-7","volume":"10","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y., et al., The value of multiparameter 18F-FDG PET\/CT imaging in differentiating retroperitoneal paragangliomas from unicentric Castleman disease. Scientific Reports, 2020. 10(1): p. 12887.","journal-title":"Scientific Reports"},{"issue":"1","key":"4139_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jso.24891","volume":"117","author":"C Messiou","year":"2018","unstructured":"Messiou, C. and C. Morosi, Imaging in retroperitoneal soft tissue sarcoma. J Surg Oncol, 2018. 117(1): p. 25-32.","journal-title":"J Surg Oncol"},{"issue":"1","key":"4139_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1148\/radiol.2241011113","volume":"224","author":"MJ Kransdorf","year":"2002","unstructured":"Kransdorf, M.J., et al., Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology, 2002. 224(1): p. 99-104.","journal-title":"Radiology"},{"issue":"supplement 1","key":"4139_CR30","first-page":"128","volume":"59","author":"Z Nina","year":"2018","unstructured":"Nina, Z., et al., <strong>The PET\/CT manifestations of different pathological subtypes of retroperitoneal liposarcoma<\/strong&gt. Journal of Nuclear Medicine, 2018. 59(supplement 1): p. 128.","journal-title":"Journal of Nuclear Medicine"},{"issue":"4","key":"4139_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/jso.26379","volume":"123","author":"S Subramaniam","year":"2021","unstructured":"Subramaniam, S., et al., The role of (18) F-FDG PET\/CT in retroperitoneal sarcomas-A multicenter retrospective study. J Surg Oncol, 2021. 123(4): p. 1081-1087.","journal-title":"J Surg Oncol"},{"issue":"4","key":"4139_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1148\/rg.314095132","volume":"31","author":"P Rajiah","year":"2011","unstructured":"Rajiah, P., et al., Imaging of uncommon retroperitoneal masses. Radiographics, 2011. 31(4): p. 949-76.","journal-title":"Radiographics"},{"issue":"4","key":"4139_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2214\/ajr.182.4.1820971","volume":"182","author":"S Beaulieu","year":"2004","unstructured":"Beaulieu, S., et al., Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. AJR Am J Roentgenol, 2004. 182(4): p. 971-4.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"4139_CR34","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2214\/AJR.07.2060","volume":"189","author":"MA Bredella","year":"2007","unstructured":"Bredella, M.A., et al., Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol, 2007. 189(4): p. 928-35.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"4139_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2967\/jnumed.114.142372","volume":"56","author":"A Chirindel","year":"2015","unstructured":"Chirindel, A., et al., 18F-FDG PET\/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization. J Nucl Med, 2015. 56(3): p. 379-85.","journal-title":"J Nucl Med"},{"key":"4139_CR36","first-page":"6162182","volume":"2016","author":"D Tovmassian","year":"2016","unstructured":"Tovmassian, D., M. Abdul Razak, and K. London, The Role of [(18)F]FDG-PET\/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1. Int J Surg Oncol, 2016. 2016: p. 6162182.","journal-title":"Int J Surg Oncol"},{"issue":"3","key":"4139_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11060-021-03936-y","volume":"156","author":"RTJ Geitenbeek","year":"2022","unstructured":"Geitenbeek, R.T.J., et al., Diagnostic value of (18)F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients. J Neurooncol, 2022. 156(3): p. 559-567.","journal-title":"J Neurooncol"},{"issue":"8","key":"4139_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","volume":"62","author":"JA Carrasquillo","year":"2021","unstructured":"Carrasquillo, J.A., et al., Imaging of Pheochromocytoma and Paraganglioma. J Nucl Med, 2021. 62(8): p. 1033-1042.","journal-title":"J Nucl Med"},{"issue":"1","key":"4139_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40644-019-0217-5","volume":"19","author":"TJ Hung","year":"2019","unstructured":"Hung, T.J., et al., The role of (18)F-FDG-PET\/CT in evaluating retroperitoneal masses -Keeping your eye on the ball! Cancer Imaging, 2019. 19(1): p. 28.","journal-title":"Cancer Imaging."},{"issue":"1040","key":"4139_CR40","doi-asserted-by":"publisher","first-page":"20140263","DOI":"10.1259\/bjr.20140263","volume":"87","author":"P Sharma","year":"2014","unstructured":"Sharma, P., et al., Diagnostic accuracy of integrated (18)F-FDG PET\/CT for restaging patients with malignant germ cell tumours. Br J Radiol, 2014. 87(1040): p. 20140263.","journal-title":"Br J Radiol"},{"issue":"supplement 2","key":"4139_CR41","first-page":"290","volume":"54","author":"H Si-Long","year":"2013","unstructured":"Si-Long, H., et al., 18F-FDG PET\/CT in the evaluation of testicular nonseminomatous germ cell cancer after orchiectomy and chemotherapy. Journal of Nuclear Medicine, 2013. 54(supplement 2): p. 290.","journal-title":"Journal of Nuclear Medicine"},{"issue":"supplement 1","key":"4139_CR42","first-page":"1070","volume":"58","author":"W Hadyn","year":"2017","unstructured":"Hadyn, W., P. Darko, and M. Colleen, <strong>FDG-PET-CT in Growing Teratoma Syndrome with Non-Seminomatous Testicular Mixed Germ Cell Tumor<\/strong>. Journal of Nuclear Medicine, 2017. 58(supplement 1): p. 1070.","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"4139_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/rg.251045045","volume":"25","author":"T Kazama","year":"2005","unstructured":"Kazama, T., et al., FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics, 2005. 25(1): p. 191-207.","journal-title":"Radiographics"},{"issue":"8","key":"4139_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1634\/theoncologist.2015-0036","volume":"20","author":"M Meignan","year":"2015","unstructured":"Meignan, M., M. Hutchings, and L.H. Schwartz, Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography. Oncologist, 2015. 20(8): p. 890-5.","journal-title":"Oncologist"},{"issue":"2","key":"4139_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1756287214565637","volume":"7","author":"S Cristian","year":"2015","unstructured":"Cristian, S., et al., Management of idiopathic retroperitoneal fibrosis from the urologist\u2019s perspective. Ther Adv Urol, 2015. 7(2): p. 85-99.","journal-title":"Ther Adv Urol"},{"issue":"4","key":"4139_CR46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.semarthrit.2017.07.011","volume":"47","author":"Y Wang","year":"2018","unstructured":"Wang, Y., et al., The value of (18)F-FDG PET\/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum, 2018. 47(4): p. 593-600.","journal-title":"Semin Arthritis Rheum"},{"issue":"supplement 1","key":"4139_CR47","first-page":"1031","volume":"52","author":"E Devrim","year":"2011","unstructured":"Devrim, E. and O. Antonio, Pattern recognition of renal FDG uptake in PET CT. Pictorial review. Journal of Nuclear Medicine, 2011. 52(supplement 1): p. 1031.","journal-title":"Journal of Nuclear Medicine"},{"issue":"4","key":"4139_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1754-9485.2010.02181.x","volume":"54","author":"R Kochhar","year":"2010","unstructured":"Kochhar, R., et al., Role of FDG PET\/CT in imaging of renal lesions. J Med Imaging Radiat Oncol, 2010. 54(4): p. 347-57.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"4139_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2214\/AJR.05.0110","volume":"186","author":"MA Blake","year":"2006","unstructured":"Blake, M.A., et al., Renal oncocytoma displaying intense activity on 18F-FDG PET. AJR Am J Roentgenol, 2006. 186(1): p. 269-70.","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"4139_CR50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.42289","volume":"5","author":"J Ferdinandus","year":"2022","unstructured":"Ferdinandus, J., et al., FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma. JAMA Netw Open, 2022. 5(11): p. e2242289.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"4139_CR51","doi-asserted-by":"publisher","first-page":"W163","DOI":"10.2214\/AJR.11.7790","volume":"199","author":"K Zukotynski","year":"2012","unstructured":"Zukotynski, K., et al., PET\/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology. AJR Am J Roentgenol, 2012. 199(2): p. W163-7.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"4139_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2214\/AJR.13.11793","volume":"203","author":"A Dong","year":"2014","unstructured":"Dong, A., et al., (18)F-FDG PET\/CT of adrenal lesions. AJR Am J Roentgenol, 2014. 203(2): p. 245-52.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"4139_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1148\/radiol.11100569","volume":"259","author":"GW Boland","year":"2011","unstructured":"Boland, G.W., et al., Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology, 2011. 259(1): p. 117-26.","journal-title":"Radiology"},{"issue":"3","key":"4139_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ejrad.2010.11.026","volume":"81","author":"L Zhou","year":"2012","unstructured":"Zhou, L., et al., Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol, 2012. 81(3): p. 401-5.","journal-title":"Eur J Radiol"},{"issue":"1","key":"4139_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","volume":"56","author":"KY Lam","year":"2002","unstructured":"Lam, K.Y. and C.Y. Lo, Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf), 2002. 56(1): p. 95-101.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"4139_CR56","first-page":"1795","volume":"42","author":"M Yun","year":"2001","unstructured":"Yun, M., et al., 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med, 2001. 42(12): p. 1795-9.","journal-title":"J Nucl Med"},{"issue":"3","key":"4139_CR57","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/jc.2005-1540","volume":"91","author":"S Leboulleux","year":"2006","unstructured":"Leboulleux, S., et al., Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab, 2006. 91(3): p. 920-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4139_CR58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/RLU.0000000000000677","volume":"40","author":"P Jha","year":"2015","unstructured":"Jha, P., et al., Hybrid imaging for pancreatic malignancy: clinical applications, merits, limitations, and pitfalls. Clin Nucl Med, 2015. 40(3): p. 206-13.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"4139_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00259-004-1689-4","volume":"32","author":"MC van Kouwen","year":"2005","unstructured":"van Kouwen, M.C., et al., FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging, 2005. 32(4): p. 399-404.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"4139_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.sla.0000172095.97787.84","volume":"242","author":"S Heinrich","year":"2005","unstructured":"Heinrich, S., et al., Positron emission tomography\/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg, 2005. 242(2): p. 235-43.","journal-title":"Ann Surg"},{"issue":"7","key":"4139_CR61","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12149-021-01629-0","volume":"35","author":"L Evangelista","year":"2021","unstructured":"Evangelista, L., et al., The role of FDG PET\/CT or PET\/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review. Ann Nucl Med, 2021. 35(7): p. 767-776.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"4139_CR62","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2214\/AJR.20.24567","volume":"217","author":"A Panda","year":"2021","unstructured":"Panda, A., et al., Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET\/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival. AJR Am J Roentgenol, 2021. 217(3): p. 730-740.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"4139_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13550-021-00808-4","volume":"11","author":"FN Harder","year":"2021","unstructured":"Harder, F.N., et al., [18F]FDG PET\/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma. EJNMMI Research, 2021. 11(1): p. 70.","journal-title":"EJNMMI Research"},{"issue":"2","key":"4139_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2967\/jnmt.114.145458","volume":"43","author":"P Jha","year":"2015","unstructured":"Jha, P. and B. Bijan, PET\/CT for Pancreatic Malignancy: Potential and Pitfalls. J Nucl Med Technol, 2015. 43(2): p. 92-7.","journal-title":"J Nucl Med Technol"},{"issue":"3","key":"4139_CR65","first-page":"145","volume":"33","author":"MM Abouzied","year":"2005","unstructured":"Abouzied, M.M., E.S. Crawford, and H.A. Nabi, 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol, 2005. 33(3): p. 145-55; quiz 162-3.","journal-title":"J Nucl Med Technol"},{"issue":"3","key":"4139_CR66","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4274\/MIRT.020573","volume":"20","author":"S Y\u0131lmaz","year":"2011","unstructured":"Y\u0131lmaz, S., et al., Metformin-Induced Intense Bowel Uptake Observed on Restaging FDG PET\/CT Study in a Patient with Gastric Lymphoma. Mol Imaging Radionucl Ther, 2011. 20(3): p. 114-6.","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"3","key":"4139_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4068\/cmj.2018.54.3.143","volume":"54","author":"J Kim","year":"2018","unstructured":"Kim, J. and H.C. Song, Role of PET\/CT in the Evaluation of Aortic Disease. Chonnam Med J, 2018. 54(3): p. 143-152.","journal-title":"Chonnam Med J"},{"issue":"5","key":"4139_CR68","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2967\/jnumed.109.072355","volume":"51","author":"JH Rudd","year":"2010","unstructured":"Rudd, J.H., The role of 18F-FDG PET in aortic dissection. J Nucl Med, 2010. 51(5): p. 667-8.","journal-title":"J Nucl Med"},{"issue":"2","key":"4139_CR69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jvs.2008.03.059","volume":"48","author":"C Reeps","year":"2008","unstructured":"Reeps, C., et al., Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission\/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg, 2008. 48(2): p. 417-23; discussion 424.","journal-title":"J Vasc Surg"},{"issue":"1","key":"4139_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejvs.2008.12.016","volume":"38","author":"CW Kotze","year":"2009","unstructured":"Kotze, C.W., et al., Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography\/computed tomography (PET\/CT). Eur J Vasc Endovasc Surg, 2009. 38(1): p. 93-9.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"4139_CR71","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1186\/s12885-023-11334-y","volume":"23","author":"X Li","year":"2023","unstructured":"Li, X. and W. Zhang, Clinical application of real-time PET\/CT guided targeted retroperitoneal masses biopsy in diagnosing malignant tumors. BMC Cancer, 2023. 23(1): p. 829.","journal-title":"BMC Cancer"},{"issue":"4","key":"4139_CR72","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s00259-018-4133-x","volume":"46","author":"R Kumar","year":"2019","unstructured":"Kumar, R., et al., Diagnostic performance of real-time robotic arm-assisted (18)F-FDG PET\/CT-guided percutaneous biopsy in metabolically active abdominal and pelvic lesions. Eur J Nucl Med Mol Imaging, 2019. 46(4): p. 838-847.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"4139_CR73","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s00259-019-04352-1","volume":"46","author":"A Moreau","year":"2019","unstructured":"Moreau, A., et al., Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET\/CT. European Journal of Nuclear Medicine and Molecular Imaging, 2019. 46(8): p. 1758-1759.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"9","key":"4139_CR74","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1093\/rheumatology\/keab264","volume":"60","author":"D Daoussis","year":"2021","unstructured":"Daoussis, D., et al., Anti-PD-1 associated retroperitoneal fibrosis. Rheumatology (Oxford), 2021. 60(9): p. e329-e330.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4139_CR75","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1097\/RLU.0000000000004513","volume":"48","author":"T Khessib","year":"2023","unstructured":"Khessib, T., et al., Retroperitoneal Inflammation Detected on FDG PET\/CT in Patient on Long-Term Immunotherapy. Clin Nucl Med, 2023. 48(4): p. e165-e166.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"4139_CR76","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1007\/s00259-016-3351-3","volume":"43","author":"V Ruhlmann","year":"2016","unstructured":"Ruhlmann, V., et al., (18)F-FDG PET\/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging, 2016. 43(9): p. 1646-52.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"4139_CR77","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1148\/rg.2021210035","volume":"41","author":"SJ Galgano","year":"2021","unstructured":"Galgano, S.J., et al., Applications of PET\/MRI in Abdominopelvic Oncology. Radiographics, 2021. 41(6): p. 1750-1765.","journal-title":"Radiographics"},{"issue":"1","key":"4139_CR78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41824-022-00144-3","volume":"6","author":"B Ronchi","year":"2022","unstructured":"Ronchi, B., G.A. Pe\u00f1a, and C. Sacchi, PET\/MR: primary inferior vena cava leiomyosarcoma. Eur J Hybrid Imaging, 2022. 6(1): p. 24.","journal-title":"Eur J Hybrid Imaging"},{"issue":"6","key":"4139_CR79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.semnuclmed.2015.02.006","volume":"45","author":"AJ Corrigan","year":"2015","unstructured":"Corrigan, A.J., P.J. Schleyer, and G.J. Cook, Pitfalls and Artifacts in the Use of PET\/CT in Oncology Imaging. Semin Nucl Med, 2015. 45(6): p. 481-99.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"4139_CR80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00592-019-01385-8","volume":"57","author":"M Finessi","year":"2020","unstructured":"Finessi, M., G. Bisi, and D. Deandreis, Hyperglycemia and 18F-FDG PET\/CT, issues and problem solving: a literature review. Acta Diabetologica, 2020. 57(3): p. 253-262.","journal-title":"Acta Diabetologica"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04139-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-04139-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04139-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:05:22Z","timestamp":1716267922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-04139-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":80,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["4139"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-04139-x","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}